WhiteLab Genomics

WhiteLab Genomics is a fast-growing in-silico deeptech start-up that is reinventing the research and early development of new genomic medicines. We are developing and using Artificial Intelligence to accelerate the discovery, design and bioproduction of these innovative biotherapies. We are collaborating with top notch academics, biotech companies, and pharmaceutical firms in Europe and North America, to tackle significant challenges in developing innovative genomic medicines notably for rare diseases, neurodegenerative diseases, oncology, ophthalmology.